On-Demand Webinar

Mechanistic Models at the Regulatory Frontier: Insights from EMA’s Qualification of the Simcyp® Simulator

The European Medicines Agency (EMA) formally qualified Certara’s Simcyp® Simulator, marking the first and only…

CertaraAugust 4, 2025

Press Release

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…

CertaraAugust 4, 2025

On-Demand Webinar

Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches

CertaraAugust 1, 2025

Blog

Machine Learning (ML) in healthcare

Learn about 3 distinct examples of machine learning (ML) in healthcare that utilize different techniques…

CertaraAugust 1, 2025

Press Release

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time…

CertaraJuly 31, 2025

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

The Japanese educational webinar series provides essential insights into in vitro data analysis and the…

CertaraJuly 30, 2025

Blog

Recapping a record-breaking 2025 Krakow HTA Symposium

We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…

Simona ColucciJuly 30, 2025

Blog

Scanning research collections against generic definitions

A case study of finding substances controlled by generic definitions in a chemical library with…

CertaraJuly 30, 2025

Blog

Challenges in implementing a reliable highly-similar detection algorithm

Dive into the challenges of creating a reliable algorithm for detecting controlled substance analogues and…

CertaraJuly 30, 2025

Mechanistic Models at the Regulatory Frontier: Insights from EMA’s Qualification of the Simcyp® Simulator

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches

Machine Learning (ML) in healthcare

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

Recapping a record-breaking 2025 Krakow HTA Symposium

Scanning research collections against generic definitions

Challenges in implementing a reliable highly-similar detection algorithm

Newsletter sign up

Quick links

Solutions

Contact